Semaglutide is evaluated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition such as type 2 diabetes, prediabetes, high blood pressure, or elevated cholesterol
Your provider will need to document medical necessity BMI, comorbidities, and prior treatment history
This isn't a complete list - review full safety information with your prescriber before starting treatment
It was also effective at reducing the need for certain heart surgeries in adults with heart disease
There was also a slight increase in the number of foot and toe amputations during the CANVAS trial than is usual so further studies are needed to assess if this is a problem and who is more at risk
They will consider your medical history, current medications, and overall health